Literature DB >> 3003868

[Neuropathy caused by cisplatin. Clinical, electrophysiological and morphological study].

J L Gastaut, J F Pellissier.   

Abstract

Seven patients with cancer presented a sensory peripheral neuropathy induced by cisplatinum. This drug was used alone in 1 case and, in 6 other cases it was associated with drugs without any toxicity for the peripheral nervous system. Every patient had an electromyogram and motor and sensory nerve conduction studies. A sural nerve biopsy was performed in 5 cases for light and electron microscopic studies as well as for teasing and quantitative studies. Electromyograms and motor nerve conductions were normal. Sensory nerve conductions were slowed with very low amplitude sensory action potentials. Such results suggested axonal changes. Nerve biopsies showed typical axonopathic changes with secondary demyelination. Morphometric studies confirmed a loss of myelinated fibers affecting the large fibers in all cases, according to the slowed sensory nerve conductions. This study confirmed that the cisplatinum-induced neuropathy is a new form of toxic distal axonal neuropathy. The hypothesis of a primary demyelination of peripheral nerves, which has been proposed, could not be retained.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3003868

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  5 in total

1.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 2.  Chemotherapy-induced peripheral neuropathy.

Authors:  Bushra Malik; Mark Stillman
Journal:  Curr Pain Headache Rep       Date:  2008-06

Review 3.  Chemotherapy-induced peripheral neuropathy.

Authors:  Bushra Malik; Mark Stillman
Journal:  Curr Neurol Neurosci Rep       Date:  2008-01       Impact factor: 5.081

4.  Cisplatin neuropathy: clinical course and neurophysiological findings.

Authors:  M LoMonaco; M Milone; A P Batocchi; L Padua; D Restuccia; P Tonali
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

5.  Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats.

Authors:  G Cavaletti; G Tredici; P Marmiroli; M G Petruccioli; I Barajon; D Fabbrica
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.